Drug Type Small molecule drug |
Synonyms Elacytarabine (USAN/INN), CP-4055, P-4055 + [2] |
Target |
Mechanism DNA inhibitors(DNA inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC27H45N3O6 |
InChIKeyFLFGNMFWNBOBGE-FNNZEKJRSA-N |
CAS Registry188181-42-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 3 | US | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | AU | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | BE | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | CA | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | FR | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | DE | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | IE | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | IT | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | NO | 01 Jun 2010 | |
Acute Myeloid Leukemia | Phase 3 | PL | 01 Jun 2010 |
Phase 3 | 381 | xbpdamupol(udoxtumuqf) = sjovnzfkch dlhwzrfksf (hsmgzqirxl ) View more | Negative | 20 Jun 2014 | |||
Investigator's choice of one of seven commonly used AML salvage regimens | xbpdamupol(udoxtumuqf) = fleolafbpr dlhwzrfksf (hsmgzqirxl ) View more | ||||||
Phase 1 | 43 | upvvxyqzxr(pizguzwuwy) = felsqcdxlv xsiqmpayuw (jmxzevcbql ) View more | Positive | 01 Mar 2014 | |||
Phase 2/3 | - | chrlwqzmvc(riocbgbtwi) = nahnzsfyok bvwawxldbe (kndxojvvcd ) | - | 15 Apr 2013 | |||
Phase 3 | 350 | zlkdrkgjtd(yhufnadouz) = uwuevdpfob givzrzxeet (uresqsonss ) View more | - | 20 May 2011 | |||
(Limited investigator's choice) | zlkdrkgjtd(yhufnadouz) = sjepyazqcd givzrzxeet (uresqsonss ) View more | ||||||
Phase 1 | 17 | jltuwsioca(rputayyakr) = qnppxojpsv rdrlysfpen (vcmdfpirjr ) | Positive | 15 Jul 2004 |